VVOS

Vivos Therapeutics, Inc. VVOS

VVOS
Vivos Therapeutics, Inc. ALUR
Allurion Technologies Inc. NVNO
enVVeno Medical Corporation CODX
Co-Diagnostics, Inc. AEMD
Aethlon Medical, Inc. COCH
Envoy Medical, Inc. ADGM
Adagio Medical Holdings, Inc. OSRH
OSR Holdings, Inc. ANL
Adlai Nortye Ltd. LPCN
Lipocine Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VVOS ALUR NVNO CODX AEMD COCH ADGM OSRH ANL LPCN
6M -32.46 % -43.50 % -91.59 % -12.85 % -84.14 % -48.32 % -16.54 % -53.43 % -6.71 % 43.96 %
YTD -51.53 % -86.67 % -88.44 % -66.68 % -96.11 % -51.34 % -9.40 % -94.87 % -37.30 % -4.32 %
1Y -56.72 % -87.17 % -88.41 % -68.25 % -94.70 % -56.43 % 0.00 % -94.87 % -30.45 % -1.48 %
3Y -81.27 % -99.45 % -92.20 % -89.75 % -98.76 % -92.52 % -88.29 % -94.87 % -89.80 % -31.62 %
5Y -98.82 % -99.43 % -95.61 % -97.60 % -99.85 % -92.32 % -88.29 % -94.87 % -89.80 % -80.32 %
10Y -99.08 % -99.43 % -99.73 % -95.86 % -100.00 % -92.32 % -88.29 % -94.87 % -89.80 % -97.88 %
From the beginning -99.08 % -99.43 % -99.73 % -95.86 % -100.00 % -92.32 % -88.29 % -94.87 % -89.80 % -97.26 %

Dividend